Navigation Links
New generation of orthopedic, dental and cardiovascular prostheses
Date:1/27/2009

This press release is available in French.

Montreal, January 27, 2008 The futuristic technology of the Six Million Dollar Man specifically a part metal and part flesh human being won't be exclusive to Hollywood anymore. While the main character in the Six Million Dollar Man was outfitted with metals to enhance his performance, a multidisciplinary team of scientists led by the Universit de Montral has discovered a process to produce new metal surfaces that promise to lead to superior medical implants that will improve healing and allow the human body to better accept metal prostheses.

According to new research published in Nano Letters, the scientists capitalized on recent advances in nanotechnology to change how metals can influence cell growth and development in the body. A critical aspect of the finding is that the surfaces can directly stimulate cells thereby eliminating the need for pharmaceuticals and resulting side-effects. The study is a collaboration between the Universit de Montral, McGill University, the Institut National de la Recherche Scientifique (INRS-EMT), Plasmionique Inc and the Universidade de So Paulo.

"Using chemical modification, we have produced metals with intelligent surfaces that positively interact with cells and help control the biological healing response," says Antonio Nanci, the study's senior author and a professor at the Universit de Montral's Faculty of Dentistry. "These will be the building-blocks of new and improved metal implants that are expected to significantly affect the success of orthopedic, dental and cardiovascular prostheses."

Etching produces nanoporous surfaces

Dr. Nanci and colleagues applied chemical compounds to modify the surface of the common biomedical metals such as titanium. Exposing these metals to selected etching mixtures of acids and oxidants results in sur
'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Page: 1 2

Related biology news :

1. Next generation microscopy: No stain, big gain
2. e-Smart Technologies to Introduce Next Generation I AM Smart Card Technology at Cartes 2008 in Paris
3. Gene therapy restores vision to mice with retinal degeneration
4. Cholesterol-lowering drugs and the effect on muscle repair and regeneration
5. Generation innovation: Young UC San Diego bioengineer to use NIH grant to fuel tissue engineering
6. ESA trains next generation of atmospheric scientists
7. Entrust Expands Relationship with Slovenia, Implements Second-generation ePassport Solution
8. Rhode Island Hospital study finds link between obesity, type 2 diabetes and neurodegeneration
9. Songbirds may hold key to advances in treatment of brain degeneration
10. Broad Institute researchers introduce next generation tool for visualizing genomic data
11. The epigenetics of increasing weight through the generations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...for 360 million years and survived when the dinosa...g to make many of them extinct, according to an ar... . , The fungus, Batrachochytrium dendrobatidi...amphibian extinctions in Central America and north...350 amphibian species by penetrating their skin, b...
(Date:11/23/2009)...x-week-old turkey poults could save millions of ma...ccording to Dr. Gerald Steiner from the Dresden Un...eir use of infrared spectroscopy to determine the ...accurate method with the potential to be used by t... eggs for breeding. The pilot study has just been ...
(Date:11/23/2009)... Interuniversity Professorship in Law and the Huma...of the Basque Country. The Professorship is largel...ch as researchers in the fields of molecular biolo...he Interuniversity Professorship in Law and the Hu...Basque Country was created in 1993. The worldwide ...
Breaking Biology News(10 mins):Rescuing male turkey chicks 2Research and legislation should go hand in hand, as much as possible 2Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 1Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 2Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 3Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 4Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 5Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 6Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 7Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 8Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 9Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 10Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 11Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 12Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 13Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 14Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 15Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 16Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 17Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 1Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 2Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 3Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 1Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 2Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 3Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 4
...in, reward and addictive behaviors. Opioids exert ... receptors, mu, delta and kappa whose genes have b...Opioid receptors in the brain are activated by a f...orphins and endorphin, which are released by neuro...usly by alkaloid opiates, the prototype of which i...
...ry J. Hannon, Ph.D., Cold Spring Harbor Laboratory...ute (HHMI) investigator, along with two other youn...rial Sloan-Kettering Cancer Centers (MSKCC) 2007 P... named after Paul A. Marks, Ph.D., President Emeri... to the basic understanding and treatment of cance...
...m aimed at linking together the world,s databases ... the Nobel Prize for Medicine awarded to Mario R. ... launched this week. , The Cambridge University... will ultimately support new medical advances and ...esearch. , Because they are so genetically simila...
Other Biology News:How does the opioid system control pain, reward and addictive behavior? 2How does the opioid system control pain, reward and addictive behavior? 3How does the opioid system control pain, reward and addictive behavior? 4Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer 2A computer for your mouse! 2
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009)...patientswithadvanced-stage,orrecurrentendometrialc...ll/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the...nendocrinetherapyandoncology,todayannouncedpositiv...xicpeptideconjugate,AEZS-108(formerlyAN-152),inpat...ersonalizedhealthcareapproach,thestudyselectedpati...
(Date:11/24/2009)...ll/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalsp...tithassubmittedaMAAtotheEuropeanMedicinesAgencyfor...erapyindevelopment,forthetreatmentofType1Gaucherdi...ucerasealfathathasbeensubmitted,withprevious,submi...lobalsupplyshortageofthecurrentlyapprovedandmarket...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...need is a good idea to make some good money. You c...me registration for a year for much less than $1 a...per month. For an additional $3 a month, get an en...fer secure online credit-card transactions. Cha-ch...n in for free. In principle you will have almost t...
...s. The Madison police department has moved to sp...ddition of an eToken USB key system provided by A...vide a robust and dependable situation thats easil...focus on protecting the city of Madison with unpar...on, said Neil Sullivan, the companys enterprise se...
...fices are located in the MG&E Innovation Center at...al research group ConjuGon announced on Tuesday ...of $1.1 million dollars from angel investors, incl...e new funds will be directed to the firms operatin...otheraputic treatments. , ,ConjuGon develops remed...
Other Biology Technology:The Wal-Mart-ization of e-commerce 2The Wal-Mart-ization of e-commerce 3Madison police adopt digital lock and key 2ConjuGon lands $1 million angel investment 2
Rabbit Anti-Potassium Channel kv3.2 Antibody, Unconjugated from Spring Bioscience
Sheep Anti-Human ErbB 2 Polyclonal Antibody, Unconjugated from Abcam
Hybridization Solution, 2 Concentrate, Buffered with SSPE from Sigma-Aldrich
Rabbit Anti-Rat Potassium Channel Kv2.2 Antibody, Unconjugated from CHEMICON
Biology Products: